RSS   Newsletter   Contact   Advertise with us
Post Online Media

Alnylam Pharma appoints Pushkal Garg as CMO

AlnylamAlnylam Pharmaceuticals, a pharmaceutical company, announced the promotion of Pushkal Garg, senior vice president, clinical development, to the role of chief medical officer.

Dr. Garg joined Alnylam in late 2014 with over 15 years of experience in early and late-stage clinical drug development, including at Bristol-Myers Squibb and Millennium Pharmaceuticals.

Article continues below

READ MORE Alnylam Pharmaceuticals adds Marsha H. Fanucci to the board

During his tenure at BMS, he was responsible for the development and successful global approvals of several medicines in the Immunoscience therapeutic area.

Dr. Garg received a Bachelor of Arts from the University of California, Berkeley, and an M.D. from the University of California, San Francisco.

Dr. Garg completed residency training in Internal Medicine at UCSF, was a research fellow at Johns Hopkins University, and served on the faculty of Harvard Medical School and the Brigham & Women's Hospital in Boston prior to joining industry.


 LATEST MOVES FROM Massachusetts 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy